Fidelity Investments’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Buy
2,291
+1,159
+102% +$240K ﹤0.01% 3161
2025
Q4
$234K Sell
1,132
-11
-1% -$2.2K ﹤0.01% 3365
2025
Q3
$205K Buy
1,143
+160
+16% +$27.2K ﹤0.01% 3333
2025
Q2
$159K Sell
983
-223
-18% -$35.5K ﹤0.01% 3408
2025
Q1
$205K Buy
1,206
+136
+13% +$23.6K ﹤0.01% 3235
2024
Q4
$178K Buy
1,070
+77
+8% +$13.2K ﹤0.01% 3316
2024
Q3
$171K Sell
993
-35
-3% -$5.79K ﹤0.01% 3252
2024
Q2
$158K Buy
1,028
+38
+4% +$5.7K ﹤0.01% 3116
2024
Q1
$152K Sell
990
-456
-32% -$69.5K ﹤0.01% 3122
2023
Q4
$229K Buy
1,446
+826
+133% +$119K ﹤0.01% 2927
2023
Q3
$90.7K Buy
620
+2
+0.3% +$305 ﹤0.01% 3130
2023
Q2
$94.6K Sell
618
-4
-0.6% -$624 ﹤0.01% 3184
2023
Q1
$96.4K Sell
622
-42
-6% -$6.6K ﹤0.01% 3219
2022
Q4
$102K Sell
664
-282
-30% -$41.6K ﹤0.01% 3202
2022
Q3
$125K Sell
946
-191
-17% -$26.8K ﹤0.01% 3197
2022
Q2
$154K Buy
1,137
+301
+36% +$41.5K ﹤0.01% 3200
2022
Q1
$125K Sell
836
-84
-9% -$12.4K ﹤0.01% 3383
2021
Q4
$149K Sell
920
-13
-1% -$2.1K ﹤0.01% 3007
2021
Q3
$155K Sell
933
-37
-4% -$6.32K ﹤0.01% 2994
2021
Q2
$167K Buy
970
+648
+201% +$107K ﹤0.01% 2952
2021
Q1
$52K Buy
322
+95
+42% +$16.3K ﹤0.01% 3037
2020
Q4
$38K Buy
227
+39
+21% +$6.33K ﹤0.01% 3049
2020
Q3
$30K Sell
188
-66
-26% -$10.8K ﹤0.01% 2972
2020
Q2
$43K Sell
254
-39
-13% -$6.12K ﹤0.01% 2832
2020
Q1
$38K Buy
293
+18
+7% +$2.56K ﹤0.01% 2823
2019
Q4
$41K Buy
275
+85
+45% +$11.7K ﹤0.01% 2938
2019
Q3
$24K Sell
190
-6
-3% -$799 ﹤0.01% 3023
2019
Q2
$28K Buy
196
+26
+15% +$3.59K ﹤0.01% 2997
2019
Q1
$25K Buy
170
+169
+16,900% +$24.3K ﹤0.01% 2922
2018
Q4
$0 Buy
+1
New +$137 ﹤0.01% 3678

Other funds holding FBT

Fidelity Investments's FBT Position: Q1 2026 in Review

Fidelity Investments increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 102% in Q1 2026, buying an estimated $240K and bringing the position to 2,291 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3161.

Fidelity Investments first reported a position in FBT in Q4 2018 and has held it in 30 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Fidelity Investments held 2,291 shares of First Trust NYSE Arca Biotechnology Index Fund worth $460K as of Q1 2026.
  • Fidelity Investments bought 1,159 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $240K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3161 holding.
  • Fidelity Investments first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and has held it in 30 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.